Esperion Stock Analysis

ESPR -  USA Stock  

USD 15.73  0.53  3.49%

The latest Esperion Theraptc price fall could raise concerns from retail investors as the firm it trading at a share price of 15.73 on 205,693 in volume. The company executives were unable to exploit market volatilities in June. However, diversifying your overall positions with Esperion Theraptc can protect your principal portfolio during market swings. The stock standard deviation of daily returns for 90 days investing horizon is currently 4.1. This high volatility is attributed to the latest market swings and not so good earnings reports for some of the Esperion Theraptc partners.
Continue to Investing Opportunities.

Search Stock Analysis 

 
Refresh
The Esperion Theraptc stock analysis report makes it easy to digest most publicly released information about Esperion Theraptc and get updates on important government artifacts, including earning estimates, SEC corporate filings, and announcements. Esperion Stock analysis module also helps to analyze the Esperion Theraptc price relationship with some important fundamental indicators such as market cap and management efficiency.

Esperion Stock Analysis Notes

About 108.0% of the company shares are held by institutions such as insurance companies. The company recorded a loss per share of 5.77. Esperion Theraptc had not issued any dividends in recent years. The entity had 1:6 split on the 11th of June 2013. Esperion Therapeutics, Inc., a pharmaceutical company, develops and commercializes medicines for the treatment of patients with elevated low-density lipoprotein cholesterol in the United States and internationally. Esperion Therapeutics, Inc. was incorporated in 2008 and is headquartered in Ann Arbor, Michigan. Esperion Theraptc operates under Biotechnology classification in the United States and is traded on NASDAQ Exchange. It employs 479 people. To learn more about Esperion Theraptc call Timothy Mayleben at 734 887-3903 or check out www.esperion.com.

Esperion Theraptc Quarterly Cost of Revenue

1.78 MillionShare

Esperion Theraptc Investment Alerts

Many investors view ongoing market volatility as an opportunity to purchase more stocks at a favorable price or short it to generate a bearish trend profit opportunity. If you are one of those investors, make sure you clearly understand the position you are entering. Esperion Theraptc's investment alerts are automatically generated signals that are significant enough to either complement your investing judgment regarding Esperion Theraptc or challenge it. These alerts can help you understand what you are buying and avoid costly mistakes.
Esperion Theraptc generates negative expected return over the last 90 days
Esperion Theraptc has high historical volatility and very poor performance
Esperion Theraptc has high likelihood to experience some financial distress in the next 2 years
The company reported the previous year's revenue of 233.68 M. Net Loss for the year was (156.24 M) with profit before overhead, payroll, taxes, and interest of 78.22 M.
Esperion Theraptc currently holds about 217.94 M in cash with (104.9 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 7.73.
Esperion Theraptc has a poor financial position based on the latest SEC disclosures
Latest headline from MacroaxisInsider: Acquisition by Foody Joanne M of 88692 shares of Esperion Theraptc subject to Rule 16b-3

Esperion Theraptc Upcoming and Recent Events

Earnings reports are used by Esperion Theraptc to provide an update of all three financial statements, including the income statement, the balance sheet, and the cash flow statement. Every quarterly earnings report provides investors with three things: an overview of sales, expenses, and net income for the most recent period. It also may provide a comparison to Esperion Theraptc previous reporting period. The quarterly earnings reports are usually disseminated to the public via Form 10-Q, which is a legal document filed with the Securities and Exchange Commission every quarter.
Upcoming Quarterly Report3rd of August 2021
Next Earnings Report1st of November 2021
Next Fiscal Quarter End30th of June 2021
Next Fiscal Year End22nd of February 2022
Last Quarter Report31st of March 2021
Last Earning Announcement30th of June 2020

Esperion Largest EPS Surprises

Earnings surprises can significantly impact Esperion Theraptc's stock price both in the short term and over time. Negative earnings surprises usually result in a price decline. However, it has been seen that positive earnings surprises lead to an immediate rise in a stock's price and a gradual increase over time. This is why we often hear news about some companies beating earning projections. Financial analysts spend a large amount of time predicting earnings per share (EPS) along with other important future indicators. Many analysts use forecasting models, management guidance, and additional fundamental information to derive an EPS estimate.
Reported
Fiscal Date
Estimated EPS
Reported EPS
Surprise
2015-03-05
2014-12-31-0.55-0.490.0610 
2013-11-06
2013-09-30-0.4-0.340.0615 
2015-05-07
2015-03-31-0.48-0.56-0.0816 
View All Earnings Estimates

Esperion Theraptc SEC Filings

SEC filings are important regulatory documents required of all public companies to provide to potential investors. Esperion Theraptc prospectus issued under the guidelines of SEC is a legal declaration of facts and statements to ensure that Esperion Theraptc investors are not misled. SEC filings are required by law to meet strict transparency standards and other important legal constraints. Although many companies may choose careful wording to disguise some material information, SEC filings make crucial Esperion Theraptc specific information freely available to individual and institutional investors to make a timely investment decision.
28th of June 2021
Financial Statements and Exhibits. Regulation FD Disclosure. Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
View
28th of May 2021
Financial Statements and Exhibits. Submission of Matters to a Vote of Security Holders. Unclassified Corporate Event
View
17th of May 2021
Financial Statements and Exhibits. Regulation FD Disclosure. Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
View
4th of May 2021
Financial Statements and Exhibits. Results of Operations and Financial Condition
View
26th of April 2021
Financial Statements and Exhibits. Other Events. Entry into a Material Definitive Agreement
View
23rd of February 2021
Financial Statements and Exhibits. Results of Operations and Financial Condition
View
16th of February 2021
Unclassified Corporate Event
View
12th of February 2021
Unclassified Corporate Event
View

Esperion Theraptc Thematic Classifications

In addition to having Esperion Theraptc stock in your portfolios, you can add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your favorite investment opportunity, you can then obtain an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility. If you are a result-oriented investor, you can benefit from optimizing one of our existing themes to build an efficient portfolio against your specific investing outlook.
Pharmaceutical Products IdeaPharmaceutical Products
USA Equities from Pharmaceutical Products industry as classified by Fama & French

Esperion Market Capitalization

The company currently falls under 'Small-Cap' category with current market capitalization of 428.52 M. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate Esperion Theraptc's market, we take the total number of its shares issued and multiply it by Esperion Theraptc's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and these looking for more risk prefer small-cap and mid-cap equities.

Esperion Profitablity

Esperion Theraptc's profitability indicators refer to fundamental financial ratios that showcase Esperion Theraptc's ability to generate income relative to its revenue or operating costs. If, let's say, Esperion Theraptc is currently losing money, the management's focus should be on how to reverse that trend. However, when revenue exceeds expenses, Esperion Theraptc's executives or investors may be in less hurry to break that information down - which is where profitability analysis comes into play. Gaining a greater understanding of Esperion Theraptc's profitability requires more research than a typical breakdown of Esperion Theraptc's financial statements. By doing a profitability analysis, companies can identify areas needing attention, and investors can make a profitable trade.
The company has Profit Margin (PM) of (66.86) %, which may suggest that it does not properly executes on its current pricing strategies or is unable to control all of the operational costs. This is way below average. Similarly, it shows Operating Margin (OM) of (49.84) %, which suggests for every $100 dollars of sales, it generated a net operating loss of -0.5.
Last ReportedProjected for 2021
Return on Investment(235.30) (253.88) 
Return on Average Assets(0.52) (0.56) 
Return on Average Equity 11.06  11.93 
Return on Invested Capital(0.69) (0.75) 
Return on Sales(0.53) (0.57) 

Management Efficiency

The entity has return on total asset (ROA) of (31.77) % which means that it has lost $31.77 on every $100 spent on asset. This is way below average. Similarly, it shows return on stockholders equity (ROE) of (260.79) %, meaning that it created substantial loss on money invested by shareholders. Esperion Theraptc management efficiency ratios could be used to measure how well esperion theraptc manages its routine affairs as well as how well it operates its assets and liabilities. As of 07/28/2021, Return on Average Equity is likely to grow to 11.93, while Return on Investment is likely to drop (253.88) . Esperion Theraptc Current Assets are relatively stable at the moment as compared to the past year. Esperion Theraptc reported last year Current Assets of 345.9 Million. As of 07/28/2021, Assets Non Current is likely to grow to about 7.6 M, while Total Assets Per Share are likely to drop 13.06.
Last ReportedProjected for 2021
Book Value per Share(3.50) (3.77) 
Enterprise Value over EBIT(6.00) (6.47) 
Enterprise Value over EBITDA(5.71) (6.16) 
Price to Book Value(7.54) (7.74) 
Tangible Assets Book Value per Share 12.86  11.41 
Enterprise Value687 M849 M
Tangible Asset Value353.2 M287.8 M

Technical Drivers

As of the 28th of July, Esperion Theraptc shows the coefficient of variation of (1,103), and Mean Deviation of 3.05. Esperion Theraptc technical analysis allows you to utilize historical prices and volume patterns in order to determine a pattern that computes the direction of the firm's future prices. Put another way, you can use this information to find out if the firm will indeed mirror its model of historical prices and volume momentum, or the prices will eventually revert. We were able to interpolate data for nineteen technical drivers for Esperion Theraptc, which can be compared to its rivals. Please confirm Esperion Theraptc standard deviation, value at risk, as well as the relationship between the Value At Risk and kurtosis to decide if Esperion Theraptc is priced favorably, providing market reflects its regular price of 15.73 per share. Given that Esperion Theraptc has jensen alpha of (0.44), we urge you to verify Esperion Theraptc's prevailing market performance to make sure the company can sustain itself at a future point.

Esperion Theraptc Price Movement Analysis

Study
Time Period
Deviations up
Deviations down
MA Type
Execute Study
The output start index for this execution was one hundred seventy-nine with a total number of output elements of eighty. The Bollinger Bands is very popular indicator that was developed by John Bollinger. It consist of three lines. Esperion Theraptc middle band is a simple moving average of its typical price. The upper and lower bands are (N) standard deviations above and below the middle band. The bands widen and narrow when the volatility of the price is higher or lower, respectively. The upper and lower bands can also be interpreted as price targets for Esperion Theraptc. When the price bounces off of the lower band and crosses the middle band, then the upper band becomes the price target. View also all equity analysis or get more info about bollinger bands overlap studies indicator.

Esperion Theraptc Insider Trading Activities

Some recent studies suggest that insider trading raises the cost of capital for securities issuers and decreases overall economic growth. Trading by specific Esperion Theraptc insiders, such as employees or executives, is commonly permitted as long as it does not rely on Esperion Theraptc's material information that is not in the public domain. Local jurisdictions usually require such trading to be reported in order to monitor insider transactions. In many U.S. states, trading conducted by corporate officers, key employees, directors, or significant shareholders must be reported to the regulator or publicly disclosed, usually within a few business days of the trade. In these cases Esperion Theraptc insiders are required to file a Form 4 with the U.S. Securities and Exchange Commission (SEC) when buying or selling shares of their own companies.
Foody Joanne M over two weeks ago via Macroaxis 
Acquisition by Foody Joanne M of 88692 shares of Esperion Theraptc subject to Rule 16b-3
Richard Bartram over three weeks ago via Macroaxis 
Acquisition by Richard Bartram of 26400 shares of Esperion Theraptc subject to Rule 16b-3
Richard Bartram over three weeks ago via Macroaxis 
Acquisition by Richard Bartram of 37500 shares of Esperion Theraptc subject to Rule 16b-3
Tracy Woody over two months ago via Macroaxis 
Acquisition by Tracy Woody of 12376 shares of Esperion Theraptc subject to Rule 16b-3
Biotech Target N V over two months ago via Macroaxis 
Purchase by Biotech Target N V of 100000 shares of Esperion Theraptc
Biotech Target N V over two months ago via Macroaxis 
Purchase by Biotech Target N V of 200000 shares of Esperion Theraptc
Koenig Sheldon L over two months ago via Macroaxis 
Acquisition by Koenig Sheldon L of 120000 shares of Esperion Theraptc subject to Rule 16b-3
Biotech Target N V over two months ago via Macroaxis 
Purchase by Biotech Target N V of 80000 shares of Esperion Theraptc
Timothy Mayleben over six months ago via Macroaxis 
Exercise or conversion by Timothy Mayleben of 10700 shares of Esperion Therapeutics subject to Rule 16b-3
Biotech Target N V over six months ago via Macroaxis 
Purchase by Biotech Target N V of 200000 shares of Esperion Therapeutics
Tracy Woody over a year ago via Macroaxis 
Acquisition by Tracy Woody of 6106 shares of Esperion Therapeutics subject to Rule 16b-3
Fuhrman Alan over a year ago via Macroaxis 
Acquisition by Fuhrman Alan of 11003 shares of Esperion Therapeutics subject to Rule 16b-3

Esperion Theraptc Predictive Daily Indicators

Esperion Theraptc intraday indicators are useful technical analysis tools used by many experienced traders. Just like the conventional technical analysis, daily indicators help intraday investors to analyze the price movement with the timing of Esperion Theraptc stock daily movement. By combining multiple daily indicators into a single trading strategy, you can limit your risk while still earning strong returns on your managed positions.

Esperion Theraptc Forecast Models

Esperion Theraptc time-series forecasting models is one of many Esperion Theraptc's stock analysis techniquest aimed to predict future share value based on previously observed values. Time-series forecasting models ae widely used for non-stationary data. Non-stationary data are called the data whose statistical properties e.g. the mean and standard deviation are not constant over time but instead, these metrics vary over time. These non-stationary Esperion Theraptc's historical data is usually called time-series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the stock market movement and maximize returns from investment trading.

About Esperion Stock Analysis

Stock analysis is the technique used by a trader or investor to examine and evaluate how Esperion Theraptc stock is reacting to, or reflecting on a current stock market direction and economic conditions. It can be used to make informed decisions about market timing, and when buying or selling Esperion shares will generate the highest return on investment. We also built our stock analysis module to help investors to gain an insight into the world economy as a whole, the stock market, thematic ideas, a specific sector, or an individual stock such as Esperion Theraptc. By using and applying Esperion Stock analysis, traders can create a robust methodology for identifying Esperion entry and exit points for their positions.
Last ReportedProjected for 2021
Operating Margin(53.35) (57.56) 
EBITDA Margin(0.53) (0.57) 
Gross Margin 0.99  0.94 
Profit Margin(0.63) (0.68) 
Esperion Therapeutics, Inc., a pharmaceutical company, develops and commercializes medicines for the treatment of patients with elevated low-density lipoprotein cholesterol in the United States and internationally. Esperion Therapeutics, Inc. was incorporated in 2008 and is headquartered in Ann Arbor, Michigan. Esperion Theraptc operates under Biotechnology classification in the United States and is traded on NASDAQ Exchange. It employs 479 people.

Current Esperion Analysis - Recommendations

We track the performance of the top 100 financial experts across various large and mid-size financial boutiques. Esperion analyst recommendations are determined by taking all analyst recommendations and averaging them as Strong Buy, Buy, Hold, Strong Sell or Sell. There is no one specific way to measure analysis performance other than comparing it to the past results via a very sophisticated attribution analysis. Esperion analyst consensus and target price projections should be used in combination with other traditional techniques such as stock price forecasting, technical analysis, earnings estimate, and various momentum models.
Target PriceAdvice# of Analysts
49.22Hold9Odds
Esperion Theraptc current and past analyst recommendations published by a number of research institutions as well as average analyst consensus.
Most Esperion analysts issue ratings four times a year, at intervals of three months. Ratings are usually accompanied by a target price to helps potential investors understand Esperion stock's fair price compared to its market value. Analysts arrive at stock ratings after researching public financial statements of Esperion Theraptc, talking to its executives and customers, or listening to Esperion conference calls.
Esperion Analyst Advice Details

Esperion Stock Analysis Indicators

Esperion Theraptc stock analysis indicators help investors evaluate how Esperion Theraptc stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing and determine when trading Esperion Theraptc shares will generate the highest return on investment. By understating and applying Esperion Theraptc stock analysis, traders can identify Esperion Theraptc position entry and exit signals to maximize returns.
Quick Ratio2.45
Fifty Two Week Low14.78
Revenue Growth333.60%
Shares Short Prior Month9.69M
Average Daily Volume Last 10 Day604.57k
Average Daily Volume In Three Month694.81k
Shares Percent Shares Out31.88%
Gross Margins38.24%
Short Percent Of Float44.85%
Forward Price Earnings-2.91
Float Shares26.23M
Fifty Two Week High41.48
Enterprise Value To Ebitda-7.76
Fifty Day Average21.03
Two Hundred Day Average25.63
Enterprise Value To Revenue3.85
Continue to Investing Opportunities. Note that the Esperion Theraptc information on this page should be used as a complementary analysis to other Esperion Theraptc's statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try Stock Tickers module to use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites.

Complementary Tools for Esperion Stock analysis

When running Esperion Theraptc price analysis, check to measure Esperion Theraptc's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Esperion Theraptc is operating at the current time. Most of Esperion Theraptc's value examination focuses on studying past and present price action to predict the probability of Esperion Theraptc's future price movements. You can analyze the entity against its peers and financial market as a whole to determine factors that move Esperion Theraptc's price. Additionally, you may evaluate how the addition of Esperion Theraptc to your portfolios can decrease your overall portfolio volatility.
Portfolio Center
All portfolio management and optimization tools to improve performance of your portfolios
Go
Transaction History
View history of all your transactions and understand their impact on performance
Go
Content Syndication
Quickly integrate customizable finance content to your own investment portal
Go
Idea Analyzer
Analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas
Go
Theme Ratings
Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance
Go
Portfolio Backtesting
Avoid under-diversification and over-optimization by backtesting your portfolios
Go
Positions Ratings
Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance
Go
The market value of Esperion Theraptc is measured differently than its book value, which is the value of Esperion that is recorded on the company's balance sheet. Investors also form their own opinion of Esperion Theraptc's value that differs from its market value or its book value, called intrinsic value, which is Esperion Theraptc's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Esperion Theraptc's market value can be influenced by many factors that don't directly affect Esperion Theraptc underlying business (such as pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Esperion Theraptc's value and its price as these two are different measures arrived at by different means. Investors typically determine Esperion Theraptc value by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Esperion Theraptc's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.